Abstract
ALTERATIONS in the intracellular concentration of cyclic 3′,5′-AMP have been implicated in the action of many hormones and pharmacological agents in a variety of tissues1. In many cases, drugs, the action of which in liver, myocardium, adrenal and other tissues has been attributed to their effects on cyclic AMP concentrations, are known to influence aggregation of blood platelets, for example, platelet aggregation is inhibited by methyl xanthines2 and reserpine3, which inhibit cyclic nucleotide phosphodiesterase4,5, and is augmented by epinephrine6, which stimulates adenyl cyclase in liver, fat cells and myocardium7. 5-Hydroxytryptamine induces platelet aggregation8; it stimulates adenyl cyclase in the liver fluke9. Prostaglandin PGE1 is a potent inhibitor of platelet clumping10; it increases the level of cyclic AMP in adipose tissue11 but in some circumstances may lower its concentration in isolated fat cells1.
Similar content being viewed by others
References
Sutherland, E. W., Robison, G. A., and Butcher, R. W., Circulation, 37, 279 (1968).
Ardlie, N. G., Glew, G., Schultz, B. C., and Schwartz, C. J., Thromb. Diath. Haemorrh., 18, 670 (1967).
Salzman, E. W., Thromb. Diath. Haemorrh., 7, 507 (1962).
Butcher, R. W., and Sutherland, E. W., J. Biol. Chem., 237, 1244 (1962).
Honda, F., and Imamura, H., Biochim. Biophys. Acta, 161, 267 (1968).
O'Brien, J. R., Nature, 200, 763 (1963).
Sutherland, E. W., Oye, I., and Butcher, R. W., Rec. Progr. Hormone Res., 21, 623 (1965).
Mitchell, J. R. A., and Sharp, A. A., Brit. J. Haematol., 10, 78 (1964).
Mansour, T. E., Sutherland, E. W., Rall, T. W., and Bueding, E., J. Biol. Chem., 235, 466 (1960).
Kloeze, J., Proc. Nobel Symposium II, 241 (Stockholm, 1966).
Butcher, R. W., and Baird, C. E., J. Biol. Chem., 243, 1713 (1968).
Gaarder, A., Jonsen, J., Laland, S., Hellem, A., and Owren, P. A., Nature, 192, 531 (1961).
Pauk, G. L., and Reddy, W. J., Anal. Biochem., 21, 298 (1967).
Brecher, G., and Cronkite, E. P., J. Appl. Physiol., 3, 365 (1950).
Grette, K., Acta Physiol. Scand., 56, Suppl. 195 (1962).
MacMillan, D. C., Nature, 211, 140 (1966).
Spaet, T. H., and Zucker, M. B., Amer. J. Physiol., 206, 1267 (1964).
Wolfe, S. M., and Shulman, N. R., Biochem. Biophys. Res. Commun., 35, 265 (1969).
Abdulla, Y. H., J. Athero. Res., 9, 171 (1969).
Zieve, P. D., and Greenough, W. B., Biochem. Biophys. Res. Commun., 35, 462 (1969).
Rysanek, K., Svehla, C., Spankova, H., and Mljnkova, M., J. Pharm. Pharmac., 20, 155 (1968).
Posternak, T., Sutherland, E. W., and Henion, W. F., Biochim. Biophys. Acta, 65, 558 (1962).
Cryer, P. E., Jarett, L., and Kipnis, D. M., Biochim. Biophys. Acta, 177, 586 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SALZMAN, E., NERI, L. Cyclic 3′,5′-Adenosine Monophosphate in Human Blood Platelets. Nature 224, 609–610 (1969). https://doi.org/10.1038/224609a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/224609a0
- Springer Nature Limited
This article is cited by
-
Platelets and cancer: a casual or causal relationship: revisited
Cancer and Metastasis Reviews (2014)
-
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteers
Psychopharmacology (1983)
-
[3H]Dihydroergonine binding to ?-adrenergic receptors in human platelets
Klinische Wochenschrift (1978)